Ronald Blue & Co. LLC increased its stake in LifePoint Health Inc (NASDAQ:LPNT) by 7.2% during the first quarter, Holdings Channel reports. The firm owned 18,556 shares of the company’s stock after buying an additional 1,248 shares during the period. Ronald Blue & Co. LLC’s holdings in LifePoint Health were worth $1,216,000 at the end of the most recent reporting period.
Other large investors also recently added to or reduced their stakes in the company. Letko Brosseau & Associates Inc. boosted its stake in LifePoint Health by 38.1% in the fourth quarter. Letko Brosseau & Associates Inc. now owns 1,386,589 shares of the company’s stock valued at $78,758,000 after buying an additional 382,785 shares during the period. LSV Asset Management boosted its stake in LifePoint Health by 56.0% in the first quarter. LSV Asset Management now owns 1,087,088 shares of the company’s stock valued at $71,204,000 after buying an additional 390,015 shares during the period. Prudential PLC boosted its stake in LifePoint Health by 36.6% in the fourth quarter. Prudential PLC now owns 586,900 shares of the company’s stock valued at $33,336,000 after buying an additional 157,400 shares during the period. First Trust Advisors LP boosted its stake in LifePoint Health by 2.4% in the first quarter. First Trust Advisors LP now owns 408,978 shares of the company’s stock valued at $26,788,000 after buying an additional 9,472 shares during the period. Finally, Nordea Investment Management AB boosted its stake in LifePoint Health by 3,757.5% in the third quarter. Nordea Investment Management AB now owns 378,383 shares of the company’s stock valued at $22,412,000 after buying an additional 368,574 shares during the period. Institutional investors and hedge funds own 99.88% of the company’s stock.
LifePoint Health Inc (NASDAQ:LPNT) traded up 1.98% during mid-day trading on Friday, reaching $61.95. The company’s stock had a trading volume of 213,539 shares. The company has a market capitalization of $2.50 billion, a PE ratio of 16.35 and a beta of 0.87. LifePoint Health Inc has a 1-year low of $50.60 and a 1-year high of $71.00. The firm has a 50 day moving average price of $62.63 and a 200-day moving average price of $60.44.
LifePoint Health (NASDAQ:LPNT) last posted its quarterly earnings data on Friday, April 28th. The company reported $1.07 EPS for the quarter, topping the Zacks’ consensus estimate of $1.01 by $0.06. LifePoint Health had a return on equity of 7.02% and a net margin of 1.93%. The company had revenue of $1.63 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the previous year, the business earned $0.85 EPS. The company’s quarterly revenue was up 3.1% compared to the same quarter last year. On average, equities analysts predict that LifePoint Health Inc will post $4.19 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “Ronald Blue & Co. LLC Has $1.216 Million Position in LifePoint Health Inc (LPNT)” was originally posted by Mideast Time and is the sole property of of Mideast Time. If you are reading this piece on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The original version of this piece can be accessed at https://www.mideasttime.com/ronald-blue-co-llc-has-1-216-million-position-in-lifepoint-health-inc-lpnt/1708805.html.
LPNT has been the subject of several analyst reports. Barclays PLC upped their price target on LifePoint Health from $58.00 to $60.00 and gave the stock an “equal weight” rating in a research note on Monday, May 1st. Mizuho upped their price target on LifePoint Health from $57.00 to $62.00 and gave the stock a “neutral” rating in a research note on Monday, March 27th. Deutsche Bank AG initiated coverage on LifePoint Health in a report on Tuesday, April 4th. They set a “hold” rating and a $68.00 price objective on the stock. TheStreet raised LifePoint Health from a “c+” rating to a “b-” rating in a report on Monday, March 13th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating on shares of LifePoint Health in a report on Tuesday, February 21st. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $64.73.
In other news, EVP John P. Bumpus sold 33,333 shares of the business’s stock in a transaction on Thursday, March 30th. The stock was sold at an average price of $65.00, for a total value of $2,166,645.00. Following the sale, the executive vice president now owns 143,829 shares of the company’s stock, valued at approximately $9,348,885. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Richard H. Evans sold 2,000 shares of the business’s stock in a transaction on Thursday, May 11th. The stock was sold at an average price of $62.88, for a total value of $125,760.00. Following the completion of the sale, the director now directly owns 17,718 shares in the company, valued at approximately $1,114,107.84. The disclosure for this sale can be found here. Insiders sold a total of 82,000 shares of company stock worth $5,274,814 in the last three months. Company insiders own 7.28% of the company’s stock.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Want to see what other hedge funds are holding LPNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifePoint Health Inc (NASDAQ:LPNT).
Receive News & Ratings for LifePoint Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.